Barry D. Quart, President and CEO at Ardea Biosciences, Inc./DE (RDEA), sold 25,000 shares at $21.15 ($530K) on 2010-05-07, disclosed to the SEC on 2010-05-07.
Scheduled sale ($530k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.15 | 22,596 | $478K | 90.2% |
| 2 | $21.70 | 2,404 | $52K | 9.8% |
| Total | $21.20 avg | 25,000 | $530K | 100% |
| Filing → |
| KNSA | SELL | 2026-02-12 | $126K | — | Filing → |
| KNSA | SELL | 2026-02-04 | $722K | — | Filing → |
| KNSA | SELL | 2025-12-17 | $1.7M | — | Filing → |